Letters
Rosiglitazone saga
Should we throw the baby out with the bathwater?
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2566 (Published 21 April 2011) Cite this as: BMJ 2011;342:d2566
- Charlotte McDonald, associate professor of medicine
- 1Division of Endocrinology, Department of Medicine, University of Western Ontario, London, ON, Canada N6A 4V2
- charlotte.mcdonald{at}sjhc.london.on.ca
The authors disapprove of doctors who prescribe thiazolidinediones but still advocate for “tight” glycaemic control.1
“Tight” control (7% glycated haemoglobin (HbA1c)) did not lead to increased mortality in the UKPDS.2 “Very tight” glycaemic control in ACCORD was associated with a small increase in mortality, for reasons unknown,3 but the results cannot be generalised to patients with newer onset diabetes. Some guidelines now …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.